Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Beximco Pharma Share Price
  4. Beximco Pharma Share Regulatory News
  5. Restoration - Beximco Pharmaceuticals Limited

Pin to quick picksBeximco Pharma Regulatory News (BXP)

Beximco Pharma Information
  • This share is currently suspended. It was suspended at a price of 42.50

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
42.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £189.60m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Restoration - Beximco Pharmaceuticals Limited

12 Nov 2024 10:00

RNS Number : 9070L
AIM
12 November 2024
 

NOTICE

 

12/11/2024 10:00am

 

RESTORATION OF TRADING ON AIM

 

BEXIMCO PHARMACEUTICALS LIMITED

 

Trading on AIM for the under mentioned securities was temporarily suspended. The suspension is lifted from 12/11/2024 10:00am, an announcement having been made.

 

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID

(B0DM5S5) (US0885792061)

 

If you have any queries relating to the above, please contact the Company's nominated adviser on +44 (0) 20 3368 3551.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
EXCGPGBCGUPCUBP
1234567
Date   Source Headline
5th Mar 20269:13 amRNSUpdate on Writ Petitions
28th Jan 20262:01 pmRNSOrder re Extension to Publish Financial Results
2nd Jan 20267:30 amRNSSuspension - Beximco Pharmaceuticals PLC
2nd Jan 20267:30 amRNSSuspension - Beximco Pharmaceuticals PLC
19th Dec 202511:00 amRNSDelay in Results & Temporary Suspension
19th Dec 202511:00 amRNSDelay in Results & Temporary Suspension
13th Nov 20254:00 pmRNSRequest of Extension to Publish Q1 Results
4th Nov 20257:00 amRNSChange of Name to Beximco Pharmaceuticals PLC.
27th Oct 20253:53 pmRNSRequest of Extension to Publish Financial Results
24th Oct 20257:00 amRNS-RAffordable treatment option for cystic fibrosis
15th Sep 20251:17 pmRNSFurther update on BSEC Order
21st May 20253:18 pmRNSUpdate on BSEC Order
28th Apr 20257:00 amRNSRequest of Extension to Publish Q3 Results
21st Mar 20253:51 pmRNSResponse to media reports and update on BSEC order
6th Mar 20257:00 amRNSUpdate on BSEC order
30th Jan 20252:59 pmRNSPayment of Cash Dividend
29th Jan 20257:01 amRNSBoard Changes
29th Jan 20257:00 amRNSHalf Year Results 2024-25
14th Jan 202511:24 amRNSBoard of Directors
30th Dec 20247:00 amRNSAnnual General Meeting Statement
19th Nov 20247:00 amRNSAGM Notification
14th Nov 20247:00 amRNSFinancial Results for the First Quarter
12th Nov 202410:00 amRNSRestoration - Beximco Pharmaceuticals Limited
12th Nov 202410:00 amRNSUpdate on Interim Order Supreme Court decision
11th Nov 202411:01 amRNSFurther re the Temporary Suspension of Trading
11th Nov 20247:30 amRNSSuspension - Beximco Pharmaceuticals Limited
7th Nov 20247:00 amRNSResults for the year ended 30 June 2024
29th Oct 20247:00 amRNSNotification of Preliminary Results and AGM
28th Oct 20242:35 pmRNSUpdate on Writ Petition and Interim Order
2nd Oct 20247:00 amRNSUpdate on Writ Petition and Interim Order
30th Sep 20247:06 amRNSClarification on Writ Petition
6th Sep 20242:17 pmRNSUpdate regarding Vice-Chairman, Salman Rahman
3rd Sep 20241:45 pmRNSCorrection and Clarification of Press Commentary
15th Aug 20247:00 amRNSStatement regarding Vice-Chairman, Salman Rahman
13th Aug 20247:00 amRNSStatement on political and business situation
30th Apr 20247:00 amRNSQ3 Financial Results
4th Mar 20247:00 amRNSAppointment of Managing Director
30th Jan 20247:00 amRNSHalf Year Results 2023-24
25th Jan 20249:53 amRNSPayment of Cash Dividend
11th Jan 202411:44 amRNSBoard Change
28th Dec 20239:40 amRNSAGM Statement
6th Nov 202312:17 pmRNSNotice of AGM
6th Nov 20237:00 amRNSFinancial Results for the First Quarter
1st Nov 20237:00 amRNSResults for the year ended 30 June 2023
20th Oct 20237:00 amRNSNotification of Preliminary Results and AGM
11th Sep 202310:17 amRNSClarification on Press Report
31st Aug 20233:51 pmRNSRe-appointment of Independent Director
2nd May 20237:00 amRNSQ3 Financial Results
11th Apr 20233:59 pmRNSHoldings in Company
31st Mar 202311:03 amRNSHoldings in Company
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CWC
CWC.L
LSE
0.00%
TED
TED.L
LSE
0.00%
FEV
Fidelity European Values
LSE
-0.12%
BRSC
BlackRock Smaller Companies Trust PLC
LSE
-0.76%
KGP
KGP.L
LSE
0.00%
Trending
LLOY
Lloyds
LSE
-0.90%
QHE
Quantum Helium
LSE
6.67%
GST
GSTechnologies
LSE
0.00%
GGP
Greatland Resources
LSE
-2.84%
80M
80 Mile
LSE
8.21%